| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Concept Taxonomy and an Instrument Hierarchy: Tools for Establishing and Evaluating the Conceptual Framework of a Patient-Reported Outcome (PRO) Instrument as Applied to Product Labeling Claims
|
Erickson, Pennifer
|
|
2009
|
12 |
8 |
p. 1158-1167
10 p.
|
artikel
|
| 2 |
Comparative Analysis of Length of Stay, Total Costs, and Treatment Success between Intravenous Moxifloxacin 400 mg and Levofloxacin 750 mg among Hospitalized Patients with Community-Acquired Pneumonia
|
Friedman, Howard
|
|
2009
|
12 |
8 |
p. 1135-1143
9 p.
|
artikel
|
| 3 |
Cost-Effectiveness of Using Clinical Risk Factors with and without DXA for Osteoporosis Screening in Postmenopausal Women
|
Mueller, Dirk
|
|
2009
|
12 |
8 |
p. 1106-1117
12 p.
|
artikel
|
| 4 |
Costs and Health Utilities Associated with Extremely Preterm Birth: Evidence from the EPICure Study
|
Petrou, Stavros
|
|
2009
|
12 |
8 |
p. 1124-1134
11 p.
|
artikel
|
| 5 |
Establishing Optimal Requirements for Content Validity: A Work in Progress
|
Fehnel, Sheri
|
|
2009
|
12 |
8 |
p. 1074-
1 p.
|
artikel
|
| 6 |
Evaluating Minimal Important Differences for the FACT-Melanoma Quality of Life Questionnaire
|
Askew, Robert L.
|
|
2009
|
12 |
8 |
p. 1144-1150
7 p.
|
artikel
|
| 7 |
Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III
|
Johnson, Michael L.
|
|
2009
|
12 |
8 |
p. 1062-1073
12 p.
|
artikel
|
| 8 |
Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II
|
Cox, Emily
|
|
2009
|
12 |
8 |
p. 1053-1061
9 p.
|
artikel
|
| 9 |
Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I
|
Berger, Marc L.
|
|
2009
|
12 |
8 |
p. 1044-1052
9 p.
|
artikel
|
| 10 |
International Comparisons in Valuing EQ-5D Health States: A Review and Analysis
|
Norman, Richard
|
|
2009
|
12 |
8 |
p. 1194-1200
7 p.
|
artikel
|
| 11 |
ISPOR Health Policy Council Proposed Good Research Practices for Comparative Effectiveness Research: Benefit or Harm?
|
Stürmer, Til
|
|
2009
|
12 |
8 |
p. 1042-1043
2 p.
|
artikel
|
| 12 |
Mapping the Cancer-Specific EORTC QLQ-C30 to the Preference-Based EQ-5D, SF-6D, and 15D Instruments
|
Kontodimopoulos, Nick
|
|
2009
|
12 |
8 |
p. 1151-1157
7 p.
|
artikel
|
| 13 |
On Guidelines for Comparative Effectiveness Research Using Nonrandomized Studies in Secondary Data Sources
|
Schneeweiss, Sebastian
|
|
2009
|
12 |
8 |
p. 1041-
1 p.
|
artikel
|
| 14 |
Patient Experiences of Continuity of Cancer Care: Development of a New Medical Care Questionnaire (MCQ) for Oncology Outpatients
|
Harley, Clare
|
|
2009
|
12 |
8 |
p. 1180-1186
7 p.
|
artikel
|
| 15 |
Probabilistic Sensitivity Analysis: Be a Bayesian
|
Boshuizen, Hendriek C.
|
|
2009
|
12 |
8 |
p. 1210-1214
5 p.
|
artikel
|
| 16 |
Psychometric Evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)—A Measure of Symptom Distress
|
Arbuckle, Robert A.
|
|
2009
|
12 |
8 |
p. 1168-1175
8 p.
|
artikel
|
| 17 |
Psychometric Properties of a German Version of the “Satisfaction with Information about Medicines Scale” (SIMS-D)
|
Mahler, Cornelia
|
|
2009
|
12 |
8 |
p. 1176-1179
4 p.
|
artikel
|
| 18 |
Reviewer Acknowledgment
|
|
|
2009
|
12 |
8 |
p. 1215-1222
8 p.
|
artikel
|
| 19 |
South Korean Time Trade-Off Values for EQ-5D Health States: Modeling with Observed Values for 101 Health States
|
Lee, Yeon-Kyeng
|
|
2009
|
12 |
8 |
p. 1187-1193
7 p.
|
artikel
|
| 20 |
The Cost-Effectiveness of Bosentan in the United Kingdom for Patients with Pulmonary Arterial Hypertension of WHO Functional Class III
|
Stevenson, Matt D.
|
|
2009
|
12 |
8 |
p. 1100-1105
6 p.
|
artikel
|
| 21 |
The Economic Value of Innovative Treatments over the Product Life Cycle: The Case of Targeted Trastuzumab Therapy for Breast Cancer
|
Garrison Jr, Louis P.
|
|
2009
|
12 |
8 |
p. 1118-1123
6 p.
|
artikel
|
| 22 |
The Imperative to Improve
|
Pashos, Chris L.
|
|
2009
|
12 |
8 |
p. 1084-1085
2 p.
|
artikel
|
| 23 |
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
|
McGhan, William F.
|
|
2009
|
12 |
8 |
p. 1086-1099
14 p.
|
artikel
|
| 24 |
Too Much Ado about Instrumental Variable Approach: Is the Cure Worse than the Disease?
|
Baser, Onur
|
|
2009
|
12 |
8 |
p. 1201-1209
9 p.
|
artikel
|
| 25 |
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report
|
Rothman, Margaret
|
|
2009
|
12 |
8 |
p. 1075-1083
9 p.
|
artikel
|
Tijdschrift beschrijving